Goldman names health stocks with promising Covid-19 efforts

Goldman Sachs analysts have created a basket of more than 20 health-care companies developing treatments, vaccines and tests for the coronavirus pandemic. The list “is not all-encompassing,” but... To view the full story, click the title link.